Walid J. Azar

Whole–genome characterization of chemoresistant ovarian cancer

Ann‐Marie Patch, Elizabeth L. Christie, Dariush Etemadmoghadam et al. · Nature · 2015 · 1.6K citations

Medicine, Genetics, Oncology +14

Inhibiting the system xC−/glutathione axis selectively targets cancers with mutant-p53 accumulation

David S. Liu, Sue Haupt, Karen G. Montgomery et al. · Nature Communications · 2017 · 324 citations · Full text

Life Sciences, Cancer Biology, Oncology +17

Selective Targeting of Cyclin E1-Amplified High-Grade Serous Ovarian Cancer by Cyclin-Dependent Kinase 2 and AKT Inhibition

George Au‐Yeung, Franziska Lang, Walid J. Azar et al. · Clinical Cancer Research · 2016 · 147 citations · Full text

Medicine, Oncology, Pharmacology +17

IGFBP-2 Enhances VEGF Gene Promoter Activity and Consequent Promotion of Angiogenesis by Neuroblastoma Cells

Walid J. Azar, Sheena H. X. Azar, Sandra Higgins et al. · Endocrinology · 2011 · 124 citations

Medicine, Molecular Biology, Oncology +16

IGFBP-2 - taking the lead in growth, metabolism and cancer

Steven W. Yau, Walid J. Azar, Matthew A. Sabin et al. · Journal of Cell Communication and Signaling · 2015 · 103 citations

Medicine, Biochemistry, Oncology +4